Clinical Study to Evaluate the Efficacy of Narie Thyroid Care in the management of Hypothyroidism
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 50
- Locations
- 1
- Primary Endpoint
- nvestigation 1. Blood Routine Examination (Blood R/E)
Study Overview
Brief Summary
This clinical study evaluates the efficacy and safety of Zeroharm Narie Thyroid Care, an Ayurvedic formulation, in patients with hypothyroidism. Participants diagnosed with hypothyroidism will receive Narie Thyroid Care tablets daily for 3 months. Two follow-up visits will be conducted at 1-month intervals to assess progress and monitor safety.
Laboratory tests, including TSH, T3, and T4, will be performed before and after treatment. Clinical symptoms such as fatigue, weight gain, cold intolerance, and mood changes will be tracked.
Patients will be monitored for any adverse events or side effects throughout the study. The primary endpoint is improvement in thyroid hormone levels and symptom relief.
Secondary endpoints include safety, compliance, and quality-of-life measures. Data will be statistically analyzed to evaluate the therapeutic effectiveness.
The study aims to validate Narie Thyroid Care as a natural support for hypothyroidism management.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Masking
- None
Eligibility Criteria
- Ages
- 18.00 Year(s) to 70.00 Year(s) (—)
- Sex
- Female
Inclusion Criteria
- •Diagnosed cases of hypothyroidism based on serum TSH,T3 and T4 levels Subjects not suffering from any significant illness (medical / surgical) Subjects willing to follow the procedures as per the study protocol and voluntarily sign an informed consent form.
Exclusion Criteria
- •Pregnant and lactating mother.
- •suffering with Chronic illness.
Outcomes
Primary Outcomes
nvestigation 1. Blood Routine Examination (Blood R/E)
Time Frame: 12 weeks
2. Thyroid Profile:
Time Frame: 12 weeks
Thyroid-Stimulating Hormone (TSH)
Time Frame: 12 weeks
Total T4 (Thyroxine)
Time Frame: 12 weeks
Total T3 (Triiodothyronine)
Time Frame: 12 weeks
Secondary Outcomes
- Waynes Index-Showing the scoring of signs and symptoms for the diagnosis of hypothyroidism(12 weeks)
Investigators
Dr Dipak Kumar Goswami
Government Ayurvedic College Jalukbari Guwahati 14 Assam